Romano Brothers AND Company Has $2.05 Million Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Romano Brothers AND Company increased its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 9.1% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 4,146 shares of the healthcare conglomerate’s stock after acquiring an additional 345 shares during the quarter. Romano Brothers AND Company’s holdings in UnitedHealth Group were worth $2,051,000 as of its most recent SEC filing.

Other large investors have also recently added to or reduced their stakes in the company. Richelieu Gestion SA acquired a new position in UnitedHealth Group in the 4th quarter valued at approximately $26,000. CGC Financial Services LLC increased its stake in shares of UnitedHealth Group by 1,000.0% during the 4th quarter. CGC Financial Services LLC now owns 55 shares of the healthcare conglomerate’s stock worth $29,000 after purchasing an additional 50 shares during the last quarter. True Wealth Design LLC acquired a new position in shares of UnitedHealth Group during the 4th quarter worth $31,000. LFA Lugano Financial Advisors SA increased its stake in shares of UnitedHealth Group by 148.1% during the 4th quarter. LFA Lugano Financial Advisors SA now owns 67 shares of the healthcare conglomerate’s stock worth $35,000 after purchasing an additional 40 shares during the last quarter. Finally, Transcendent Capital Group LLC acquired a new position in shares of UnitedHealth Group during the 4th quarter worth $40,000. Institutional investors and hedge funds own 87.86% of the company’s stock.

UnitedHealth Group Trading Up 4.7 %

UNH opened at $509.26 on Friday. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.69. The stock has a market capitalization of $468.72 billion, a PE ratio of 31.13, a PEG ratio of 1.48 and a beta of 0.58. UnitedHealth Group Incorporated has a 1-year low of $436.38 and a 1-year high of $554.70. The firm has a 50-day moving average price of $498.34 and a two-hundred day moving average price of $501.96.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share for the quarter, beating the consensus estimate of $6.63 by $0.28. The firm had revenue of $99.80 billion during the quarter, compared to analysts’ expectations of $99.23 billion. UnitedHealth Group had a net margin of 4.05% and a return on equity of 26.50%. The company’s quarterly revenue was up 8.6% compared to the same quarter last year. During the same quarter last year, the company posted $6.26 EPS. As a group, equities analysts anticipate that UnitedHealth Group Incorporated will post 27.55 earnings per share for the current fiscal year.

UnitedHealth Group Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Tuesday, June 25th. Stockholders of record on Monday, June 17th were given a dividend of $2.10 per share. This is a boost from UnitedHealth Group’s previous quarterly dividend of $1.88. The ex-dividend date of this dividend was Monday, June 17th. This represents a $8.40 annualized dividend and a dividend yield of 1.65%. UnitedHealth Group’s payout ratio is currently 51.34%.

Wall Street Analysts Forecast Growth

Several research analysts have recently commented on UNH shares. StockNews.com lowered shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Friday. Wells Fargo & Company decreased their price objective on shares of UnitedHealth Group from $600.00 to $525.00 and set an “overweight” rating for the company in a report on Monday, April 8th. Bank of America reaffirmed a “buy” rating and set a $675.00 price objective on shares of UnitedHealth Group in a report on Thursday, March 7th. Piper Sandler upped their price objective on shares of UnitedHealth Group from $566.00 to $571.00 and gave the stock an “overweight” rating in a report on Wednesday, April 17th. Finally, Robert W. Baird began coverage on shares of UnitedHealth Group in a report on Thursday, May 30th. They set an “outperform” rating and a $597.00 price objective for the company. Three equities research analysts have rated the stock with a hold rating, seventeen have issued a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat.com, UnitedHealth Group currently has an average rating of “Moderate Buy” and an average price target of $579.74.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.